As more novel ophthalmic drugs and devices become available under the CMS “pass-through”designation, practices should be proactive in embracing these products.
Patti Barkey, COE, OCS
Advertisement
Articles by Patti Barkey, COE, OCS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
.png "Optometry Times"){kind=logo}
